AJANTPHARM: FY26 saw record revenue and profit, led by branded generics and US generics growth
AJANTPHARM: FY26 saw record revenue and profit, led by branded generics and US generics growth
AJANTPHARM: FY26 saw record revenue and profit, led by branded generics and US generics growth
Sector
BROAD_MARKET
News Type
MARKET
Impact Level
HIGH
AI Sentiment
POSITIVE
Published
08 May 2026
📎 Sources
Quartr | https://www.tradingview.com/news/urn:summary_document_slides:quartr.com:3284365:0-ajantpharm-fy26-saw-record-revenue-and-profit-led-by-branded-generics-and-us-generics-growth/